Steven Gillis, Director at bluebird bio, Inc. (BLUE), sold 57,435 shares at $35.16 ($2.0M) on 2014-10-06, disclosed to the SEC on 2014-10-07.
Open-market sale of $2.0M BLUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.74 | 26,635 | $952K | 46.8% |
| 2 | $35.16 | 24,100 | $847K | 41.6% |
| 3 | $35.15 | 6,700 | $236K | 11.6% |
| Total | $35.43 avg | 57,435 | $2.0M | 100% |
| Filing → |
| BOLD | BUY | 2024-04-04 | $3.2M | — | Filing → |
| VBIV | BUY | 2023-07-18 | $2.0M | — | Filing → |
| CDAK | BUY | 2020-10-20 | $3.5M | — | Filing → |